SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QDEL - Quidel more quick diagnosis
QDEL 24.35+14.3%Nov 21 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dennis C who wrote (610)4/14/1997 12:35:00 PM
From: Michael Bakunin   of 1693
 
> how much of rev. or earnings could be affected

Unfortunately, lots. I'd have to double-check, but I think their pregnancy products (the ones that could be affected by Becton's suit) account for over half of revenues and earnings.

Certainly, Quidel has value outside of these products. However, if Becton were to prevail, or by threat of aggressive litigation exact some sort of monetary concession, it would have a substantial deleterious effect.

Anyone have a clue as to the legal merits of the suit?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News